Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Oncology Therapies
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -47,32% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -47,32% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
James Breitmeyer
FOU | Founder | 70 | 01/01/97 |
Richard Vincent
DFI | Director of Finance/CFO | 61 | 01/04/17 |
Salim Yazji
CTO | Chief Tech/Sci/R&D Officer | 55 | 17/05/21 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 51 | 28/08/19 |
Pablo Urbaneja
PRN | Corporate Officer/Principal | - | 01/07/21 |
Anita Wiseth
HRO | Human Resources Officer | - | 01/03/21 |
Chase Leavitt
LAW | General Counsel | 42 | 12/04/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
David Hale
FOU | Founder | 75 | 01/01/97 |
Dan Kisner
BRD | Director/Board Member | 77 | 07/06/19 |
Rosemary Mazanet
BRD | Director/Board Member | 67 | 27/01/21 |
James Breitmeyer
FOU | Founder | 70 | 01/01/97 |
William LaRue
BRD | Director/Board Member | 73 | 01/12/17 |
Michael Carter
BRD | Director/Board Member | 86 | 07/06/19 |
Charles Theuer
BRD | Director/Board Member | 60 | 01/05/18 |
Jill DeSimone
BRD | Director/Board Member | 68 | 03/01/23 |
Robert Wills
BRD | Director/Board Member | 70 | 07/06/19 |
Xin Nakanishi
BRD | Director/Board Member | 62 | 01/11/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 2 959 645 | 2 686 463 ( 90,77 %) | 0 | 90,77 % |
Coordinate società
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+17,96% | 44,96 Mrd | |
+1,17% | 42,65 Mrd | |
+48,77% | 41,85 Mrd | |
-4,27% | 29,04 Mrd | |
+11,42% | 26,08 Mrd | |
-21,39% | 19,03 Mrd | |
+4,86% | 12,75 Mrd | |
+27,29% | 12,06 Mrd | |
-3,50% | 11,75 Mrd |